w w w . L a w y e r S e r v i c e s . i n



Abbott Healthcare Pvt. Ltd. v/s Competition Commission of India & Another


Company & Directors' Information:- ABBOTT HEALTHCARE PRIVATE LIMITED [Active] CIN = U24200MH1997PTC104834

Company & Directors' Information:- ABBOTT INDIA LIMITED [Active] CIN = L24239MH1944PLC007330

Company & Directors' Information:- R G S HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110PB2004PTC047381

Company & Directors' Information:- R G S HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110CH2004PTC027689

Company & Directors' Information:- P. H. HEALTHCARE PRIVATE LIMITED [Active] CIN = U33110MH2010PTC208651

Company & Directors' Information:- B G P HEALTHCARE PRIVATE LIMITED [Active] CIN = U24232GJ2007PTC050417

Company & Directors' Information:- D R HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110GJ2006PTC048008

Company & Directors' Information:- M J HEALTHCARE PRIVATE LIMITED [Active] CIN = U93090PN2008PTC132455

Company & Directors' Information:- S J HEALTHCARE PRIVATE LIMITED [Active] CIN = U85190MH2005PTC153435

Company & Directors' Information:- G J HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110PB1998PTC021049

Company & Directors' Information:- I M HEALTHCARE PRIVATE LIMITED [Active] CIN = U24232CH2010PTC032454

Company & Directors' Information:- K G HEALTHCARE LIMITED [Active] CIN = U85110TZ1995PLC006402

Company & Directors' Information:- C S HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110GJ2012PTC070018

Company & Directors' Information:- M M HEALTHCARE LIMITED [Active] CIN = U74899DL1988PLC034339

Company & Directors' Information:- A L B HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U85110UP2002PTC026786

Company & Directors' Information:- S B M HEALTHCARE (INDIA) PRIVATE LIMITED [Active] CIN = U33112DL2005PTC140703

Company & Directors' Information:- THE INDIA COMPANY PRIVATE LIMITED [Active] CIN = U74999TN1919PTC000911

Company & Directors' Information:- S A HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U85100OR2014PTC018365

Company & Directors' Information:- AND HEALTHCARE LIMITED [Active] CIN = U51909PB2017PLC046446

Company & Directors' Information:- D. S. HEALTHCARE PRIVATE LIMITED [Active] CIN = U24232WB2007PTC115617

Company & Directors' Information:- B N HEALTHCARE PRIVATE LIMITED [Active] CIN = U15412AS2000PTC006258

Company & Directors' Information:- P AND B HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U24230GJ2013PTC075056

Company & Directors' Information:- M M D HEALTHCARE LIMITED [Active] CIN = U65921CH1996PLC017595

Company & Directors' Information:- A AND R HEALTHCARE PRIVATE LIMITED [Active] CIN = U24239DL1999PTC102404

Company & Directors' Information:- K. N. HEALTHCARE PRIVATE LIMITED [Active] CIN = U85320RJ2018PTC061003

Company & Directors' Information:- R F B HEALTHCARE PRIVATE LIMITED [Active] CIN = U85190DL2021PTC384643

Company & Directors' Information:- M S HEALTHCARE PRIVATE LIMITED [Active] CIN = U24239MH2001PTC130893

Company & Directors' Information:- INDIA CORPORATION PRIVATE LIMITED [Active] CIN = U65990MH1941PTC003461

Company & Directors' Information:- G A S HEALTHCARE PRIVATE LIMITED [Active] CIN = U74999BR2018PTC038700

Company & Directors' Information:- L. J. HEALTHCARE PRIVATE LIMITED [Active] CIN = U85100HR2019PTC078493

Company & Directors' Information:- J. R. HEALTHCARE PRIVATE LIMITED [Active] CIN = U85191UP2013PTC054982

Company & Directors' Information:- M A P H HEALTHCARE PRIVATE LIMITED [Under Process of Striking Off] CIN = U85100WB2010PTC144870

Company & Directors' Information:- N. C. HEALTHCARE PRIVATE LIMITED [Active] CIN = U85191DL2007PTC164437

Company & Directors' Information:- N Y HEALTHCARE PRIVATE LIMITED [Active] CIN = U24230GJ2010PTC063348

Company & Directors' Information:- H 4 HEALTHCARE PRIVATE LIMITED [Active] CIN = U15100MH2021PTC353283

Company & Directors' Information:- D. B. HEALTHCARE PRIVATE LIMITED [Active] CIN = U33205MH2014PTC253439

Company & Directors' Information:- K S V HEALTHCARE PRIVATE LIMITED [Active] CIN = U85195HR2011PTC043767

Company & Directors' Information:- N M HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110MH2000PTC125392

Company & Directors' Information:- T K HEALTHCARE (INDIA ) PRIVATE LIMITED [Strike Off] CIN = U85190MH2003PTC139346

Company & Directors' Information:- A R HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110CH2013PTC034820

Company & Directors' Information:- I P HEALTHCARE PRIVATE LIMITED [Active] CIN = U24239DL2003PTC121211

Company & Directors' Information:- A 2 Z HEALTHCARE PRIVATE LIMITED [Active] CIN = U85100DL2010PTC208860

Company & Directors' Information:- K. D. HEALTHCARE INDIA PRIVATE LIMITED [Strike Off] CIN = U85100DL2015PTC281658

Company & Directors' Information:- A P HEALTHCARE PRIVATE LIMITED [Active] CIN = U24230MH1999PTC122520

Company & Directors' Information:- K Y O S HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U51397HP2010PTC031280

Company & Directors' Information:- Z F HEALTHCARE PVT. LTD. [Active] CIN = U29295MH2006PTC164255

Company & Directors' Information:- K. B. B. K. HEALTHCARE PRIVATE LIMITED [Active] CIN = U85110RJ2013PTC041465

Company & Directors' Information:- T.H.E. HEALTHCARE COMPANY PRIVATE LIMITED [Strike Off] CIN = U33111MH2012PTC229451

Company & Directors' Information:- J S B HEALTHCARE PRIVATE LIMITED [Active] CIN = U74120MH2013PTC248848

Company & Directors' Information:- J S D HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U74120UP2011PTC046578

Company & Directors' Information:- S V T HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U85100TZ2009PTC015287

Company & Directors' Information:- A N S HEALTHCARE PRIVATE LIMITED [Active] CIN = U85100HP2011PTC031745

Company & Directors' Information:- J M HEALTHCARE PRIVATE LIMITED [Active] CIN = U24230CH2007PTC030943

Company & Directors' Information:- P R HEALTHCARE PRIVATE LIMITED. [Strike Off] CIN = U24231DL2003PTC120123

Company & Directors' Information:- R S M HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U24232DL2005PTC136255

Company & Directors' Information:- M H HEALTHCARE PRIVATE LIMITED [Active] CIN = U74999DL2016PTC289311

Company & Directors' Information:- N T HEALTHCARE PRIVATE LIMITED [Active] CIN = U85100DL2012PTC241304

Company & Directors' Information:- R A HEALTHCARE PRIVATE LIMITED [Strike Off] CIN = U85190DL2009PTC188221

Company & Directors' Information:- G & G HEALTHCARE PRIVATE LIMITED [Active] CIN = U51397HR2015PTC057293

Company & Directors' Information:- P D HEALTHCARE PRIVATE LIMITED [Active] CIN = U24230GJ2004PTC045131

Company & Directors' Information:- L. V. G. HEALTHCARE PRIVATE LIMITED [Active] CIN = U24233GJ2006PTC047749

Company & Directors' Information:- S H G HEALTHCARE PVT LTD [Strike Off] CIN = U85110WB1989PTC047231

    LPA. No. 658 of 2018, CM. Nos. 49071-49075 of 2018

    Decided On, 28 November 2018

    At, High Court of Delhi

    By, THE HONOURABLE CHIEF JUSTICE MR. RAJENDER MENON & THE HONOURABLE MR. JUSTICE V. KAMESWAR RAO

    For the Appellant: Sandeep Sethi, Sr. Advocate, Raj Shekhar Rao, Aashish Gupta, Aditya Mukherjee, Aman Sethi, Anirudh Lekhi, Anjali Kumar, Advocates. For the Respondents: Samar Bansal, Manan Shishodia, Devahuti Pathak, Advocates, Manish Mohan, CGSC.



Judgment Text

V. Kameswar Rao, J.

Oral:

CM No. 49073/2018 (for exemption)

Exemption allowed, subject to all just exceptions.

Application stands disposed of.

LPA 658/2018

1. The present appeal has been filed by the appellant challenging the order dated November 13, 2018 passed by the learned Single Judge in W.P. (C) 12129/2018, whereby the learned Single Judge has dismissed the writ petition. The challenge in the writ petition was to an order dated July 05, 2017 passed by the Competition Commission of India (hereinafter ‘CCI’) under Section 26(1) of the Competition Act, 2002 (hereinafter ‘the Act of 2002’), whereby the Commission has directed the Director General to cause an investigation into the matter and submit an investigation report within 60 days from the receipt of the said order.

2. The appellant has also impugned an order dated October 29, 2018 passed by the CCI rejecting the appellant’s application for review and recall of the impugned order dated July 05, 2017. It is noted from the record that the proceedings before the CCI were commenced pursuant to a letter dated March 22, 2017 received from the National Pharmaceutical Pricing Authority, Department of Pharmaceuticals (NPPA) requesting the CCI to analyse the alleged anti-competitive agreement between four leading pharmaceutical companies namely, Novartis India, Abbott Healthcare Pvt. Ltd. (appellant herein), USV Ltd., and Emcure Pharmaceutical Limited. The allegation against the said manufactures is that they were controlling the prices of the oral diabetes drugs containing the Active Pharmaceutical Ingredient (API) Vildagliptin. In addition to the pricing data furnished by NPPA, the CCI also had also received an anonymous e-mail enclosing therewith an e-mail dated July 29, 2016 purportedly sent by one of the employees of the appellant, which indicated that there was an understanding to maintain the price of drugs across the country.

3. The plea on behalf of the appellant before the learned Single Judge was; (i) the CCI was required to take an informed view regarding both the veracity of the e-mail as well as also the data provided by NPPA so as to form a prima facie opinion; (ii) without considering the appellant’s contentions, the CCI could not have formed a prima facie view, which it was required to form in terms of Section 26 of the Act, more so in light of Section 36(2) of the Act of 2002, which expressly conferred with CCI the powers of a Civil Court under the Code of Civil Procedure which includes summoning and enforcing the attendance of any person; and (iii) Regulation 17(2) of the Competition Commission of India (General) Regulations, 2009 in terms of which the Commission is empowered to invite the information provider and such other person as is necessary for a preliminary conference. In substance, it was the submission on behalf of the appellant before the learned Single Judge that it was incumbent upon the CCI to exercise such powers and form a prima facie view after conducting due enquiry.

4. Suffice it to state that the learned Single Judge has in paras 7 and 8 held as under to dismiss the writ petition:

'7. This Court is not persuaded to accept any of the contentions advanced by the learned counsel on behalf of the petitioner. As explained by the Supreme Court in Competition Commission of India v. Steel Authority of India Ltd. and Anr.: (2010) 10 SCC 744, the order passed by the CCI under Section 26 (1) is, essentially, an administrative order and akin to a direction from one wing of the department to another. Under Section 26(1) of the Act, CCI can at best direct investigation and this does not amount to an adjudicatory function. The court had further observed as under:

'92....The investigation is directed with dual purpose: (a) to collect material and verify the information, as may be, directed by the Commission, (b) to enable the Commission to examine the report upon its submission by the Director General and to pass appropriate orders after hearing the parties concerned. No inquiry commences prior to the direction issued to the Director General for conducting the investigation. Therefore, even from the practical point of view, it will be required that undue time is not spent at the preliminary stage of formation of prima facie opinion and the matters are dealt with effectively and expeditiously.

93. We may also usefully note that the functions performed by the Commission under Section 26(1) of the Act are in the nature of preparatory measures in contrast to the decision-making process. That is the precise reason that the legislature has used the word 'direction' to be issued to the Director General for investigation in that provision and not that the Commission shall take a decision or pass an order directing inquiry into the allegations made in the reference to the Commission.'

8. The provisions of Section 36 and Regulations 17, 41 and 44 also relate to the powers of the CCI to take evidence and call for information. Clearly, this is not a case where the powers of the CCI are in question. The CCI would have a jurisdiction to exercise its powers in the manner in accordance with provisions of the Act. The contention that it was incumbent upon the CCI to first take evidence under Section 36(2) of the Act or Regulation 41 of the Regulations, is bereft of any merit. As explained by the Supreme Court in Steel Authority of India (supra), the decision under Section 26(1) is only a preparatory measure, which precedes an inquiry.'

5. Mr. Sandeep Sethi, learned Senior Counsel appearing for the appellant has drawn our attention to various documents in support of his contention, that (1) the said e-mail is a forgery and could not have been relied upon, (2) the letter received from NPPA has been contested by the appellant and rather the NPPA response before the Commission only strengthened the appellant’s contention that the data submitted by NPPA which had been relied upon by the Commission on the passing the order under Section 26(1) was incorrect.

6. He has referred to the judgment of the Supreme Court in the case of Competition Commission of India vs. Steel Authority of India Ltd. and Anr. (2010) 10 SCC 744, as relied upon by the learned Single Judge to contend that reliance placed by the learned Single Judge on this judgment is totally misplaced.

7. According to him, the Supreme Court, in the very same judgment has held that the Commission, upon receiving any information alleging violation of the Act, must first satisfy itself and express an opinion that a prima facie violation exists, from the record produced before it, and thereafter pass a direction to the Director General to cause an investigation to be made into the matter. It is his submission that the judgement relied upon by the learned Single Judge itself makes it manifestly clear that the Commission must first apply its mind to the material on record, ascertaining the authenticity and accuracy of the material supplied along with the information/reference, before forming a prima facie opinion. According to him, formation of a prima facie opinion is sine qua non for directing the Director General to conduct an investigation.

8. We are not in agreement with the submissions made by Mr. Sethi. On a perusal of the judgment of the Supreme Court in Competition Commission of India (supra), the Supreme Court in paras 21, 38 and 91, has held as under:

'21. The informant, i.e. the person who wishes to complain to the Commission constituted under section 1 of the Act, would make such information available in writing to the Commission. Of course, such information could also be received from the Central Government, State Government, Statutory authority or on its own knowledge as provided under Section 19(1)(a) of the Act. When such information is received, the Commission is expected to satisfy itself and express its opinion that a prima facie case exists, from the record produced before it and then to pass a direction to the Director General to cause an investigation to be made into the matter. This direction, normally, could be issued by the Commission with or without assistance from other quarters including experts of eminence. The provisions of Section 19 do not suggest that any notice is required to be given to the informant, affected party or any other person at that stage. Such parties cannot claim the right to notice or hearing but it is always open to the Commission to call any `such person', for rendering assistance or produce such records, as the Commission may consider appropriate.

38. In contradistinction, the direction under Section 26(1) after formation of a prima facie opinion is a direction simpliciter to cause an investigation into the matter. Issuance of such a direction, at the face of it, is an administrative direction to one of its own wings departmentally and is without entering upon any adjudicatory process. It does not effectively determine any right or obligation of the parties to the lis. Closure of the case causes determination of rights and affects a party, i.e. the informant; resultantly, the said party has a right to appeal against such closure of case under Section 26(2) of the Act. On the other hand, mere direction for investigation to one of the wings of the Commission is akin to a departmental proceeding which does not entail civil consequences for any person, particularly, in light of the strict confidentiality that is expected to be maintained by the Commission in terms of Section 57of the Act and Regulation 35 of the Regulations.

91. The jurisdiction of the Commission, to act under this provision, does not contemplate any adjudicatory function. The Commission is not expected to give notice to the parties, i.e. the informant or the affected parties and hear them at length, before forming its opinion. The function is of a very preliminary nature and in fact, in common parlance, it is a departmental function. At that stage, it does not condemn any person and therefore, application of audi alteram partem is not called for. Formation of a prima facie opinion departmentally (Director General, being appointed by the Central Government to assist the Commission, is one of the wings of the Commission itself) does not amount to an adjudicatory function but is merely of administrative nature. At best, it can direct the investigation to be conducted and report to be submitted to the Commission itself or close the case in terms of Section 26(2) of the Act, which order itself is appealable before the Tribunal and only after this stage, there is a specific right of notice and hearing available to the aggrieved/affected party. Thus, keeping in mind the nature of the functions required to be performed by the Commission in terms of Section 26(1), we are of the considered view that the right of notice of hearing is not contemplated under the provisions of Section 26(1) of the Act.'

9. From the reading of the aforesaid the following position of law emerges:

1. Upon receiving the information from any person including Central Government, State Government, Statutory Authority or on its own knowledge under Section 19 (1)(a) of the Act, the commission is expected to satisfy itself and express its opinion that a prima facie case exists and then pass a direction to the Director General to cause an investigation into the matter in terms of Section 26 (1).

2. This direction under Section 26 (1) to the Director General may be passed with or without seeking assistance from any other quarters including experts of eminence or the affected parties themselves. The aggrieved / affected parties cannot claim a right to notice or hearing at this stage.

3. Issuance of a di

Please Login To View The Full Judgment!

rection by the Commission under Section 26 (1) of the Act is a direction simplicitor to cause a investigation and is administrative in nature to one of its own wings departmentally. It does not effectively determine any right or obligation of the parties to the lis. Such direction for investigation to one of the wings of the commission is akin to a departmental proceedings and does not entail civil consequences for any person. 4. The subject provision does not contemplate any adjudicatory action on the part of the Commission. The Commission is not expected to give notice to the parties and hear them at length. It is of a very preliminary nature. 5. It is only after consideration of the report of the Director General and passing of an order in terms of Section 26 (2) of the Act that the aggrieved / affected parties gain a specific right of notice and hearing. 10. In view of the above position of law, we agree with the conclusion arrived at by the learned Single Judge which we have already reproduced above. We do not see any merit in the appeal, and the same is dismissed. The time granted by the DG for furnishing information is extended for a period of three weeks from today. CM Nos. 49071/2018, 49072/2018, 49074/2018 & 49075/2018 Dismissed as infructuous.
O R